Venus Remedies Limited has informed the Exchange regarding 'Update on Resolution of Income Tax Matters and Elimination of Contingent Liability'.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Venus Remedies Limited has informed the stock exchange about progress on resolving its pending income tax matters. The update indicates that a contingent liability that was previously disclosed has now been eliminated, meaning the company no longer carries this potential financial obligation on its books. This removes uncertainty around the tax dispute and its possible financial impact. The exact quantum of the liability resolved and the tax years involved are not specified in the headline.
This is a positive development for shareholders as it removes a previously disclosed risk overhang. Elimination of contingent liability strengthens the company's balance sheet perception and reduces uncertainty, which can be viewed favorably by the market.